Protective effects of Jiashen Prescription () on myocardial infarction in rats

Chin J Integr Med. 2015 Jun;21(6):417-22. doi: 10.1007/s11655-014-1751-4. Epub 2014 May 10.

Abstract

Objective: To evaluate the effects of Jiashen Prescription (, JSP) on myocardial infarction (MI) size and cardiac function at the early stage of MI in rats.

Methods: One hundred male Sprague-Dawley rats were subjected to sham-operation or MI induced by ligating the left anterior descending coronary artery. The rats with MI were treated with vehicle, JSP 3 and 6 g/(kg·d), or losartan 10 mg/(kg·d) for 1 week.

Results: Compared with the vehicle-treated MI rats, 6 g/(kg·d) JSP reduced MI size 3 days after MI (P<0.05), and attenuated the MI-induced increases in left ventricular end-diastolic and end-systolic dimension and decreases in fractional shortening and ejection fraction 1 week after MI (P<0.05). In addition, 6 g/(kg·d) JSP and losartan were equally effective in reducing MI size and enhancing cardiac functional recovery.

Conclusion: JSP reduces MI size and improves cardiac function after MI, suggesting that JSP has potential as a therapy for MI.

MeSH terms

  • Animals
  • Body Weight
  • Cardiotonic Agents / therapeutic use*
  • Drugs, Chinese Herbal / therapeutic use*
  • Heart Function Tests
  • Male
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology
  • Myocardium / pathology
  • Organ Size
  • Rats, Sprague-Dawley
  • Survival Analysis
  • Ultrasonography

Substances

  • Cardiotonic Agents
  • Drugs, Chinese Herbal
  • jiashen